1. Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis
   Sedigheh Taghinezhad-S et al, 2021, Cellular and Molecular Life Sciences CrossRef
2. Exploiting Prophage-Mediated Lysis for Biotherapeutic Release by Lactobacillus reuteri
   Laura M. Alexander et al, 2019, Applied and Environmental Microbiology CrossRef
3. Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy
   Agata Górska et al, 2019, Current Microbiology CrossRef
4. The Use of Probiotics as Vaccine Vectors to Prevent Viral Infections
   Bachar ISMAIL, 2017, New Insights on Antiviral Probiotics CrossRef
5. Synthetic biology in probiotic lactic acid bacteria: At the frontier of living therapeutics
   Zachary JS Mays et al, 2018, Current Opinion in Biotechnology CrossRef
6. Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System
   Prashant L. Patil et al, 2023, Current Pharmaceutical Biotechnology CrossRef
7. Engineering Lactic Acid Bacteria and Bifidobacteria for Mucosal Delivery of Health Molecules
   Thibault Allain et al, 2015, Biotechnology of Lactic Acid Bacteria CrossRef
8. Anti-cancer activity of human gastrointestinal bacteria
   Sameer Quazi, 2022, Medical Oncology CrossRef
9. Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review
   Shehzeen Noor et al, 2023, Molecular Biology Reports CrossRef
10. Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
    Tinglu Li et al, 2018, Oncology Letters CrossRef
11. From promotion to management: The wide impact of bacteria on cancer and its treatment
    Ernesto Perez‐Chanona et al, 2014, BioEssays CrossRef
12. Antitumor Effect of a DNA Vaccine Harboring Prostate Cancer-Specific Antigen with IL-12 as an Intramolecular Adjuvant
    Yu Yang et al, 2017, Microbial Physiology CrossRef
13. Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides
    Tina Vida Plavec et al, 2019, Applied Microbiology and Biotechnology CrossRef
14. Recombinant lactic acid bacteria as promising vectors for mucosal vaccination
    Nan Qiao et al, 2021, Exploration CrossRef
15. Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines
    null Vilander et al, 2019, Vaccines CrossRef
16. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
    Ali Akgul et al, 2021, Arthritis Research & Therapy CrossRef
17. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
    Olivia Cano-Garrido et al, 2015, Microbial Cell Factories CrossRef
18. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease
    Sedigheh Taghinezhad-S et al, 2021, Vaccines CrossRef
19. Delivery of IL-35 by Lactococcus lactis Ameliorates Collagen-Induced Arthritis in Mice
    Massimo Maddaloni et al, 2018, Frontiers in Immunology CrossRef
20. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option
    Miao Wang et al, 2016, Applied Microbiology and Biotechnology CrossRef